Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Product › Details

MG4101 cell-based therapeutic (Green Cross)

	Next higher product group	cell therapy product_o
	Status	2016-06-02 development p2 existent
	Organisation	Green Cross LabCell Corporation (GC LabCell) (KRX: 114510)
	Group	Green Cross (GC) (KR) (Group)

Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for cell therapy product_o

[1] Poltreg S.A.. (3/11/24). "Press Release: Poltreg’s State-of-the-Art Manufacturing Facility Has Received Approval to Produce Cellular Therapies from the Chief Pharmaceutical Inspectorate in Poland"....
[2] Poltreg S.A.. (2/21/24). "Press Release: Poltreg Appoints Dan Shelly, PhD, MBA as Chief Business Development Officer to Help It Build Partnerships across Industry and Deliver Milestones"....
[3] TolerogenixX GmbH. (7/6/23). "Press Release: TolerogenixX Expands Phase II Immune-tolerance Trial and Closes EUR 12 million Series A Financing"....
[4] Neogap Therapeutics AB. (5/4/23). "Press Release: Neogap and Cellerys Enter Collaboration Related to Phase II Study of a New Therapy for Multiple Sclerosis"....
[5] CRISPR Therapeutics AG. (3/27/23). "Press Release: CRISPR Therapeutics and Vertex Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes". Boston, MA & Zug....
[6] Sernova Corporation. (1/10/23). "Press Release: Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes". London, ON....
[7] Evotec SE. (5/17/22). "Press Release: Evotec and Sernova Announce Exclusive Strategic Partnership for iPSC-based Beta Cell Replacement Therapy to Advance a 'Functional Cure' for Diabetes". Hamburg & London, ON....
[8] Bone Therapeutics S.A.. (5/12/22). "Press Release: Bone Therapeutics Enters into Exclusive Reverse Merger Discussions with Medsenic". Mont-Saint-Guibert....
[9] Bone Therapeutics S.A.. (4/29/22). "Press Release: Bone Therapeutics Announces 2021 Full Year Results". Mont-Saint-Guibert....
[10] Bone Therapeutics S.A.. (4/12/22). "Press Release: Bone Therapeutics Secures EUR 5 Million Financing [Not for US, AU, CA, et al.]". Mont-Saint-Guibert....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]